W R Grace And Co -conn, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is FENOPROFEN CALCIUM, USP+BP, with a corresponding US DMF Number 6843.
Remarkably, this DMF maintains an Active status since its submission on March 03, 1987, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 29, 2019, and payment made on March 11, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II